96 related articles for article (PubMed ID: 6185633)
1. Altered expression of rabies virus antigenic determinants associated with chronic infection and virulence.
Prabhakar BS; Parks NF; Clark HF
J Gen Virol; 1983 Jan; 64 (Pt 1)():251-4. PubMed ID: 6185633
[No Abstract] [Full Text] [Related]
2. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. II. The glycoprotein.
Flamand A; Wiktor TJ; Koprowski H
J Gen Virol; 1980 May; 48(1):105-9. PubMed ID: 6155432
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a new virus-neutralizing epitope that denotes a sequential determinant on the rabies virus glycoprotein.
Bunschoten H; Gore M; Claassen IJ; Uytdehaag FG; Dietzschold B; Wunner WH; Osterhaus AD
J Gen Virol; 1989 Feb; 70 ( Pt 2)():291-8. PubMed ID: 2471786
[TBL] [Abstract][Full Text] [Related]
4. [Antigenic variants of the rabies virus. Selection with antiglycoprotein monoclonal antibodies].
Coulon P; Rollin P; Aubert M; Flamand A
Arch Inst Pasteur Tunis; 1982 Mar; 59(1):105-13. PubMed ID: 7181560
[No Abstract] [Full Text] [Related]
5. Molecular basis of rabies virus virulence. I. Selection of avirulent mutants of the CVS strain with anti-G monoclonal antibodies.
Coulon P; Rollin P; Aubert M; Flamand A
J Gen Virol; 1982 Jul; 61 (Pt l)():97-100. PubMed ID: 6181189
[No Abstract] [Full Text] [Related]
6. Use of hybridoma monoclonal antibodies in the detection of antigenic differences between rabies and rabies-related virus proteins. I. The nucleocapsid protein.
Flamand A; Wiktor TJ; Koprowski H
J Gen Virol; 1980 May; 48(1):97-104. PubMed ID: 6155436
[TBL] [Abstract][Full Text] [Related]
7. [Avirulent mutants of the rabies virus: change in site III of the glycoprotein].
Diallo A
Ann Rech Vet; 1986; 17(1):3-6. PubMed ID: 2430498
[TBL] [Abstract][Full Text] [Related]
8. Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence.
Prehaud C; Coulon P; LaFay F; Thiers C; Flamand A
J Virol; 1988 Jan; 62(1):1-7. PubMed ID: 2446011
[TBL] [Abstract][Full Text] [Related]
9. Molecular basis of rabies virus virulence. II. Identification of a site on the CVS glycoprotein associated with virulence.
Coulon P; Rollin PE; Flamand A
J Gen Virol; 1983 Mar; 64 Pt 3():693-6. PubMed ID: 6827249
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the antigenic structure of rabies virus glycoprotein by monoclonal antibodies.
Lafon M; Ideler J; Wunner WH
Dev Biol Stand; 1984; 57():219-25. PubMed ID: 6084612
[TBL] [Abstract][Full Text] [Related]
11. Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus.
Dietzschold B; Wunner WH; Wiktor TJ; Lopes AD; Lafon M; Smith CL; Koprowski H
Proc Natl Acad Sci U S A; 1983 Jan; 80(1):70-4. PubMed ID: 6185960
[TBL] [Abstract][Full Text] [Related]
12. Virulence of chick embryo fibroblast-passaged flury HEP rabies virus and its revertants in mice.
Arai YT
Microbiol Immunol; 1985; 29(9):811-23. PubMed ID: 3906372
[TBL] [Abstract][Full Text] [Related]
13. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
[TBL] [Abstract][Full Text] [Related]
14. Protection against rabies in mice by a cytotoxic T cell clone recognizing the glycoprotein of rabies virus.
Kawano H; Mifune K; Ohuchi M; Mannen K; Cho S; Hiramatsu K; Shichijo A
J Gen Virol; 1990 Feb; 71 ( Pt 2)():281-7. PubMed ID: 2307962
[TBL] [Abstract][Full Text] [Related]
15. Properties of rabies strain ("Pasteur Potsdam") adapted to primary dog kidney cells.
Egert J; Apitzsch L; Triquart B; Sinnecker H
Acta Virol; 1989 Dec; 33(6):553-8. PubMed ID: 2483605
[TBL] [Abstract][Full Text] [Related]
16. Some characteristics of persistent rabies virus infection in cell cultures.
Suzuki M; Ohtani S; Oya A
Asian J Infect Dis; 1979 Mar; 3(1):19-26. PubMed ID: 496710
[TBL] [Abstract][Full Text] [Related]
17. Preparation and initial application of a monoclonal antibody specific for a newly discovered conserved linear epitope of rabies virus nucleoprotein.
Lv XJ; Ma XJ; Wang LH; Li H; Shen XX; Yu PC; Tang Q; Liang GD
Biomed Environ Sci; 2012 Feb; 25(1):98-103. PubMed ID: 22424633
[TBL] [Abstract][Full Text] [Related]
18. Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein.
Bunschoten H; Klapmuts RJ; Claassen IJ; Reyneveld SD; Osterhaus AD; Uytdehaag FG
J Gen Virol; 1989 Jun; 70 ( Pt 6)():1513-21. PubMed ID: 2471814
[TBL] [Abstract][Full Text] [Related]
19. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
Sureau P; Rollin P; Lafon M
Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
[TBL] [Abstract][Full Text] [Related]
20. [Rabies virus glycoprotein: structure, immunogenicity and pathogenic role].
Ross B A; Favi C M; Vásquez V A
Rev Chilena Infectol; 2008 Apr; 25(2):S14-8. PubMed ID: 18425218
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
